These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 176792)

  • 21. Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.
    Fleischmann WR; Georgiades JA; Osborne LC; Johnson HM
    Infect Immun; 1979 Oct; 26(1):248-53. PubMed ID: 227796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host-dependent restriction of mengovirus replication. IV. Effect of some quaternary ammonium ions on the restricted replication of mengovirus in Madin-Darby bovine kidney cells.
    Prather SO; Taylor MW
    J Virol; 1975 Apr; 15(4):1033-6. PubMed ID: 163914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection.
    Edy VG; Billiau A; De Somer P
    J Gen Virol; 1976 May; 31(2):251-5. PubMed ID: 180244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein leakage from mengovirus-infected cells.
    Bubel HC
    Proc Soc Exp Biol Med; 1967 Jul; 125(3):783-6. PubMed ID: 15938266
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of interferon-induced antiviral states: contrasting profiles of decay in response to the removal of MuIFN-alpha, MuIFN-beta and MuIFN-gamma.
    Ramamurthy V; Fleischmann WR
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1645-52. PubMed ID: 3016159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of microbial growth inhibitory factors.
    Fahlbusch B; Schumann I
    Acta Biol Med Ger; 1979; 38(5-6):813-9. PubMed ID: 230677
    [No Abstract]   [Full Text] [Related]  

  • 27. Dipyridamole, an inhibitor of mengovirus replication in FL and L cells.
    Tonew M; Dzeguze D
    Chemotherapy; 1977; 23(3):149-58. PubMed ID: 189976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations on structure-activity relationships with mengovirus of substituted 5-amino-4-cyanopyrazoles.
    Willitzer H; Tonew M; Lippmann E
    Antimicrob Agents Chemother; 1976 Mar; 9(3):367-70. PubMed ID: 176931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine interferon system regulation: isolation and characterization of a mutant 3T6 cell engaged in the semiconstitutive synthesis of interferon.
    Jarvis AP; Colby C
    Cell; 1978 Jun; 14(2):355-63. PubMed ID: 208779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA.
    Falcoff R; Falcoff E; Sanceau J; Lewis JA
    Virology; 1978 May; 86(2):507-15. PubMed ID: 208258
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of L cells persistently infected with VSV: factors involved in the regulation of persistent infection.
    Nishiyama Y
    J Gen Virol; 1977 May; 35(2):265-79. PubMed ID: 195007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon induction by viruses. VII. Mengovirus: "interferon-sensitive" mutant phenotype attributed to interferon-inducing particle activity.
    Marcus PI; Guidon PT; Sekellick MJ
    J Interferon Res; 1981; 1(4):601-11. PubMed ID: 6180093
    [No Abstract]   [Full Text] [Related]  

  • 34. Mode of action in vitro against mengovirus of substituted 5-amino-4-cyanopyrazoles.
    Tonew M; Lippmann E; Willitzer H
    Antimicrob Agents Chemother; 1976 Mar; 9(3):371-4. PubMed ID: 176932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased initiation factor activity in mouse L cells treated with interferon.
    Ohtsuki K; Dianzani F; Baron S
    Nature; 1977 Oct; 269(5628):536-8. PubMed ID: 909608
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lawalle M; De Clercq E; Imai J; Torrence P; Content J
    FEBS Lett; 1986 Mar; 198(2):326-32. PubMed ID: 2420642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of the action of interferon.
    Levy HB; Carter WA
    J Mol Biol; 1968 Feb; 31(3):561-77. PubMed ID: 4295315
    [No Abstract]   [Full Text] [Related]  

  • 38. Priming of interferon action.
    Fleischmann WR
    Tex Rep Biol Med; 1977; 35():316-25. PubMed ID: 616670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus.
    Metz DH; Esteban M
    Nature; 1972 Aug; 238(5364):385-8. PubMed ID: 4559581
    [No Abstract]   [Full Text] [Related]  

  • 40. Further evidences that priming is a non-antiviral function of interferon.
    Rosztóczy I
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):305-9. PubMed ID: 4372864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.